Target intelligence / Profile preview

Hypoxic tissue microenvironment

Molecular classification
Other
01

Overview

The hypoxic tissue microenvironment refers to regions within tissues where the partial pressure of oxygen is significantly lower than normal physiological levels, often observed in the core of solid tumors, sites of intense inflammation, and ischemic tissue. This hypoxic state profoundly alters cellular behavior—promoting metabolic reprogramming (glycolysis), immune evasion, angiogenesis, and tissue remodeling. The primary molecular mediators are hypoxia-inducible factors (HIFs), which regulate the expression of numerous genes that enable adaptation and survival under low oxygen. In cancer, hypoxic microenvironments are closely associated with therapy resistance, aggressive tumor phenotypes, and poor prognosis. Although the microenvironment cannot be targeted directly as a molecule, drugs that modulate hypoxia signaling or exploit hypoxic conditions are under development; monitoring hypoxic regions is also important for patient stratification and assessment of therapeutic efficacy.

Other names
Tumor hypoxiahypoxic microenvironmenttissue hypoxiahypoxic niche
02

Mechanism of action

Inhibition of HIF stabilization or function; selective cytotoxicity under hypoxic conditions; inhibition of adaptation to anaerobic metabolism; blockade of hypoxia-induced angiogenesis.

03

Biological functions

Regulation of cellular metabolism (glycolytic shift)Tissue remodeling and extracellular matrix regulationImmune modulation/immune escapePromotion of angiogenesisRegulation of cell proliferation and survival
04

Disease associations

Cancer (promotes tumor progression, metastasis, therapy resistance)Autoimmune disease (amplifies inflammation, modulates immune cells)Ischemic injury and cardiovascular diseaseInflammatory diseases (e.g., colitis, arthritis)
05

Safety considerations

Potential off-tumor effects in normal tissues undergoing physiological hypoxia (e.g., wound healing, gut mucosa)Toxicity from impaired adaptation to hypoxia in healthy tissuesDrug resistance due to heterogeneity of hypoxia and microenvironment
06

Interacting drugs

Hypoxia-activated prodrugs (e.g., evofosfamide)

3 more in the full profile.

07

Biomarkers

HIF-1α and HIF-2α protein expressionGlucose transporter 1 (GLUT1)Carbonic anhydrase IX (CAIX)Lactate levels/pH/acidification markersImaging markers (e.g., pimonidazole staining for tissue hypoxia, FMISO-PET)

Beyond the preview

Go deeper on Hypoxic tissue microenvironment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hypoxic tissue microenvironment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call